Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Revolution Medicines, Inc. - Common Stock (NQ: RVMD )

39.20 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6
Open 39.20
Bid (Size) 36.72 (1)
Ask (Size) 45.18 (1)
Prev. Close 39.20
Today's Range 39.20 - 39.20
52wk Range 29.55 - 62.40
Shares Outstanding 106,313,250
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga

Performance

YTD
-10.91%
-10.91%
1 Month
-6.80%
-6.80%
3 Month
-15.57%
-15.57%
6 Month
-5.90%
-5.90%
1 Year
+16.84%
+16.84%

More News

Read More
Nvidia, Micron, Arlo Technologies And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Revolution Medicines Inc. (NASDAQ: RVMD) Climbs to New 52-Week High
Via Investor Brand Network
Revolution Medicines's Earnings: A Preview
Via Benzinga
What 6 Analyst Ratings Have To Say About Revolution Medicines
Via Benzinga
Earnings Scheduled For February 26, 2025
Via Benzinga
Top 3 Health Care Stocks That Could Blast Off In December
Via Benzinga
Dow Dips 150 Points; ISM Manufacturing PMI Tops Estimates
Via Benzinga
Topics Stocks
Exposures US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Stellantis, PG&E And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter
Via Benzinga
The 7 Most Undervalued Under-$50 Stocks to Buy in June 2024
Via InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
Via InvestorPlace
RVMD Stock Earnings: Revolution Medicines Beats EPS for Q1 2024
Via InvestorPlace
Top 3 Health Care Stocks That May Collapse In Q2
Via Benzinga
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
What's Going On With Revolution Medicines Stock?
Via Benzinga
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Morgan Stanley Maintains Equal-Weight Rating for Revolution Medicines: Here's What You Need To Know
Via Benzinga
Uncovering Noteworthy Technical Analysis Findings for REVOLUTION MEDICINES INC (NASDAQ:RVMD).
Via Chartmill
Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
Via InvestorPlace
Earnings Scheduled For February 26, 2024
Via Benzinga
3 Biotech Stocks That Could Boom or Bust by 2025
Via InvestorPlace
Cancer Player Revolution Medicines Gets Bullish Rating: Here's Details
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.